Fulgent Genetics, Inc. — Director's Dealing 2022

Jan 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2022-01-03

Reporting Person: KIM PAUL (CFO and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-03	Common Stock	G	4000	$0.00	Disposed	116943	Direct

Footnotes

F1: Reflects shares transferred as a gift to a donor advised fund (the "Fund"). The Reporting Person disclaims beneficial ownership over the shares held by the Fund.